Showing results (11-20 of 4,587) with videos related to
Sort By:
Pageof 459
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 21, 2014
[Advances of immunotherapy in small cell lung cancer]Jingjing Liu, Shuang Zhang, Hui Li, et al.Journal of Thoracic Disease|January 22, 2024
A retrospective analysis of prognostic factors and treatment choices in small cell lung cancer with liver metastasisShuang Zhang, Yansu Wang, Shuang Li, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 12, 2018
[Advances on Recognizing and Managing Tumor Heterogeneity]Rui Zhong, Hui Li, Shuang Zhang, et al.International Journal of Clinical and Experimental Pathology|May 3, 2013
RNAi screening identifies KAT8 as a key molecule important for cancer cell survivalShuang Zhang, Xianhong Liu, Yong Zhang, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 3, 2018
[Research Progress of Immunotherapy for Brain Metastases in Patients
with Drive Gene Negative NSCLC]Shuang Zhang, Jingjing Liu, Changliang Yang, et al.Frontiers in Oncology|August 2, 2021
Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung CancerShuang Zhang, Shuang Li, Yanan Cui, et al.Journal of Thoracic Disease|January 7, 2020
The effect of PD-L1/PD-1 immunotherapy in the treatment of squamous non-small-cell lung cancer: a meta-analysis of randomized controlled clinical trialsShuang Li, Shuang Zhang, Jingjing Liu, et al.Thoracic Cancer|December 23, 2019
Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR-ANXA2, EGFR-RAD51, ATR and BRCA2 mutations: A case reportRui Zhong, Hui Li, Yanling Liu, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 6, 2020
[Highlights of PAPR Inhibitors in Small Cell Lung Cancer]Shuang Zhang, Jingjing Liu, Changliang Yang, et al.Chinese Medical Journal|June 16, 2021
Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancerYing Cheng, Hui Li, Liang Zhang, et al.Pageof 459